Advertisement

ADIPOQ gene polymorphisms and haplotypes linked to altered susceptibility to PCOS: a case–control study

      Highlights

      • A study to investigate the role of ADIPOQ variants in altering the risk of PCOS.
      • ADIPOQ rs182052, rs822393, rs822396, rs7649121, rs3774261, and rs6773957 were linked to PCOS.
      • Specific ADIPOQ haplotypes were positively and negatively associated with PCOS.
      • An ethnic contribution to ADIPOQ association with PCOS was established.

      Abstract

      Research question

      What role do ADIPOQ variants play in controlling adiponectin concentrations and altered risk of polycystic ovary syndrome (PCOS)?

      Design

      Study subjects comprised 583 women with PCOS and 713 age-matched controls. Genotyping of rs182052, rs822393, rs822396, rs7649121, rs3774271, rs266729, rs3774261 and rs6773957 ADIPOQ polymorphisms was done by real-time polymerase chain reaction (PCR).

      Results

      Of the 16 ADIPOQ variants, the minor allele frequencies of rs182052, rs822393, rs822396, rs7649121, rs3774261 and rs6773957 were significantly different between PCOS cases and controls. Significant differences in rs266729 (P = 0.02), rs822396 (P = 0.02), rs3774261 (P < 0.001) and rs6773957 (P < 0.001) genotypes were also noted between PCOS cases and controls. Reduced PCOS risk was found with heterozygous rs266729, while increased risk was linked to heterozygous rs822396 and homozygous minor allele rs3774361, and in heterozygous and homozygous minor allele rs6773957 genotype carriers. Haplotype analysis identified two blocks based on linkage disequilibrium pattern; alleles coded as ‘1’ (major) and ‘2’ (minor). Within Block 1 (rs4632532, rs16861194, rs266729, rs182052, rs16861209, rs822393, rs822395, rs822396, rs7649121), haplotypes 111111111 and 212211221 were positively, while haplotypes 212212112 and 212211211 were negatively associated with PCOS. Within Block 2 (rs2241766, rs1501299, rs2241767, rs3774261, rs6773957, rs1063539) haplotypes 111221 and 112221 were positively, while haplotype 111111 was negatively associated with PCOS.

      Conclusions

      This is the first study to confirm the association of rs182052, rs822393, rs7649121 and rs6773957 ADIPOQ variants with altered risk of PCOS. The varied association of ADIPOQ variants with PCOS in relation to earlier reports indicate there is an ethnic contribution to ADIPOQ association with PCOS.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Reproductive BioMedicine Online
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Abu-Hijleh T.M.
        • Gammoh E.
        • Al-Busaidi A.S.
        • Malalla Z.H.
        • Madan S.
        • Mahmood N.
        • Almawi W.Y.
        Common variants in the sex hormone-binding globulin (SHBG) gene influence SHBG levels in women with polycystic ovary syndrome.
        Ann. Nutr. Metab. 2016; 68: 66-74
        • Al-Awadi A.M.
        • Sarray S.
        • Arekat M.R.
        • Saleh L.R.
        • Mahmood N.
        • Almawi W.Y.
        The high-molecular weight multimer form of adiponectin is a useful marker of polycystic ovary syndrome in Bahraini Arab women.
        Clin. Nutr. ESPEN. 2016; 13: e33-e38
        • Alfaqih M.A.
        • Khader Y.S.
        • Al-Dwairi A.N.
        • Alzoubi A.
        • Al-Shboul O.
        • Hatim A.
        Lower levels of serum adiponectin and the T allele of rs1501299 of the ADIPOQ gene are protective against polycystic ovarian syndrome in Jordan.
        Korean J. Fam. Med. 2018; 39: 108-113
        • Almawi W.Y.
        • Gammoh E.
        • Malalla Z.H.
        • Al-Madhi S.A.
        Analysis of VEGFA variants and changes in VEGF levels underscores the contribution of VEGF to polycystic ovary syndrome.
        PLoS One. 2016; 11e0165636
        • Baba T.
        • Endo T.
        • Sata F.
        • Nagasawa K.
        • Honnma H.
        • Kitajima Y.
        • Hayashi T.
        • Manase K.
        • Kanaya M.
        • Moriwaka O.
        • Kamiya H.
        • Yamada H.
        • Minakami H.
        • Kishi R.
        • Saito T.
        The contributions of resistin and adiponectin gene single nucleotide polymorphisms to the genetic risk for polycystic ovary syndrome in a Japanese population.
        Gynecol. Endocrinol. 2009; 25: 498-503
        • Belenkaia L.V.
        • Lazareva L.M.
        • Walker W.
        • Lizneva D.V.
        • Suturina L.V.
        Criteria, phenotypes and prevalence of polycystic ovary syndrome.
        Minerva Ginecol. 2019; 71: 211-223
        • Brzana J.
        • Yedinak C.G.
        • Hameed N.
        • Plesiu A.
        • McCartney S.
        • Fleseriu M.
        Polycystic ovarian syndrome and Cushing's syndrome: a persistent diagnostic quandary.
        Eur. J. Obstet. Gynecol. Reprod. Biol. 2014; 175: 145-148
        • Chaudhary H.
        • Patel J.
        • Jain N.K.
        • Joshi R.
        The role of polymorphism in various potential genes on polycystic ovary syndrome susceptibility and pathogenesis.
        J. Ovarian Res. 2021; 14: 125
        • Clément A.A.
        • Lacaille M.
        • Lounis M.A.
        • Biertho L.D.
        • Richard D.
        • Lemieux I.
        • Bergeron J.
        • Mounier C.
        • Joanisse D.R.
        • Mauriège P.
        Intra-abdominal adipose depot variation in adipogenesis, lipogenesis, angiogenesis, and fibrosis gene expression and relationships with insulin resistance and inflammation in premenopausal women with severe obesity.
        J. Physiol. Biochem. 2022; 78: 527-542
        • Crespo R.P.
        • Bachega T.A.S.S.
        • Mendonça B.B.
        • Gomes L.G.
        An update of genetic basis of PCOS pathogenesis.
        Arch. Endocrinol. Metab. 2018; 62: 352-361
        • Czeczuga-Semeniuk E.
        • Galar M.
        • Jarząbek K.
        • Kozłowski P.
        • Sarosiek N.A.
        • Wołczyński S.
        The preliminary association study of ADIPOQ, RBP4, and BCMO1 variants with polycystic ovary syndrome and with biochemical characteristics in a cohort of Polish women.
        Adv. Med. Sci. 2018; 63: 242-248
        • Dallel M.
        • Douma Z.
        • Finan R.R.
        • Hachani F.
        • Letaifa D.B.
        • Mahjoub T.
        • Almawi W.Y.
        Contrasting association of leptin receptor polymorphisms and haplotypes with polycystic ovary syndrome in Bahraini and Tunisian women: a case-control study.
        Biosci. Rep. 2021; 41BSR20202726
        • Dallel M.
        • Sghaier I.
        • Finan R.R.
        • Douma Z.
        • Hachani F.
        • Letaifa D.B.
        • Mahjoub T.
        • Almawi W.Y.
        Circulating leptin concentration, LEP gene variants and haplotypes, and polycystic ovary syndrome in Bahraini and Tunisian Arab women.
        Gene. 2019; 694: 19-25
        • Dapas M.
        • Dunaif A.
        Deconstructing a syndrome: genomic insights into PCOS causal mechanisms and classification.
        Endocr. Rev. 2022; (bnac001 (online ahead of print)
        • Demirci H.
        • Yilmaz M.
        • Ergun M.A.
        • Yurtcu E.
        • Bukan N.
        • Ayvaz G.
        Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.
        Gynecol. Endocrinol. 2010; 26: 348-355
        • Dendana M.
        • Bahia W.
        • Finan R.R.
        • Al-Mutawa M.
        • Almawi W.Y.
        Association of adiponectin gene variants with idiopathic recurrent miscarriage according to obesity status: a case-control study.
        J. Transl. Med. 2018; 16: 76
        • Douma Z.
        • Dallel M.
        • Bahia W.
        • Ben Salem A.
        • Hachani Ben Ali F.
        • Almawi W.Y.
        • Lautier C.
        • Haydar S.
        • Grigorescu F.
        • Mahjoub T.
        Association of estrogen receptor gene variants (ESR1 and ESR2) with polycystic ovary syndrome in Tunisia.
        Gene. 2020; 741144560
        • Escobar-Morreale H.F.
        • Villuendas G.
        • Botella-Carretero J.I.
        • Alvarez-Blasco F.
        • Sanchón R.
        • Luque-Ramírez M.
        • San Millán J.L.
        Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study.
        Hum. Reprod. 2006; 21: 2257-2265
        • Ezzidi I.
        • Mtiraoui N.
        • Mohmmed Ali M.E.
        • Al Masoudi A.
        • Abu Duhier F.
        Adiponectin (ADIPOQ) gene variants and haplotypes in Saudi Arabian women with polycystic ovary syndrome (PCOS): a case-control study.
        Gynecol. Endocrinol. 2020; 36: 66-71
        • Haap M.
        • Machicao F.
        • Stefan N.
        • Thamer C.
        • Tschritter O.
        • Schnuck F.
        • Wallwiener D.
        • Stumvoll M.
        • Häring H.U.
        • Fritsche A.
        Genetic determinants of insulin action in polycystic ovary syndrome.
        Exp. Clin. Endocrinol. Diabetes. 2005; 113: 275-281
        • Heid I.M.
        • Wagner S.A.
        • Gohlke H.
        • Iglseder B.
        • Mueller J.C.
        • Cip P.
        • Ladurner G.
        • Reiter R.
        • Stadlmayr A.
        • Mackevics V.
        • Illig T.
        • Kronenberg F.
        • Paulweber B.
        Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians.
        Diabetes. 2006; 55: 375-384
        • Heinonen S.
        • Korhonen S.
        • Helisalmi S.
        • Koivunen R.
        • Tapanainen J.
        • Hippeläinen M.
        • Laakso M.
        Associations between two single nucleotide polymorphisms in the adiponectin gene and polycystic ovary syndrome.
        Gynecol. Endocrinol. 2005; 21: 165-169
        • Hivert M.F.
        • Manning A.K.
        • McAteer J.B.
        • Florez J.C.
        • Dupuis J.
        • Fox C.S.
        • O'Donnell C.J.
        • Cupples L.A.
        • Meigs J.B.
        Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study.
        Diabetes. 2008; 57: 3353-3359
        • Jamshidi M.
        • Mohammadi Pour S.
        • Bahadoram M.
        • Mahmoudian-Sani M.R.
        • Saeedi Boroujeni A.
        Genetic polymorphisms associated with polycystic ovary syndrome among Iranian women.
        Int. J. Gynaecol. Obstet. 2021; 153: 33-44
        • Jia H.
        • Yu L.
        • Guo X.
        • Gao W.
        • Jiang Z.
        Associations of adiponectin gene polymorphisms with polycystic ovary syndrome: a meta-analysis.
        Endocrine. 2012; 42: 299-306
        • Jiang L.
        • Zhu X.
        • Rong J.
        • Xing B.
        • Wang S.
        • Liu A.
        • Chu M.
        • Huang G.
        Obesity, osteoarthritis and genetic risk: the rs182052 polymorphism in the ADIPOQ gene is potentially associated with risk of knee osteoarthritis.
        Bone Joint Res. 2018; 7: 494-500
        • Kabel A.M.
        Polycystic ovarian syndrome: insights into pathogenesis, diagnosis, prognosis, pharmacological and non-pharmacological treatment.
        Pharm. Bioprocess. 2016; 4: 7-12
        • Kalyan S.
        • Goshtesabi A.
        • Sarray S.
        • Joannou A.
        • Almawi W.Y.
        Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics.
        BMJ Open. 2018; 8e021860
        • Kim J.J.
        • Choi Y.M.
        • Hong M.A.
        • Kim J.M.
        • Hwang S.S.
        • Lee G.H.
        • Chae S.J.
        • Hwang K.R.
        • Yoon S.H.
        • Kim S.H.
        Gene dose effect between a fat mass and obesity-associated polymorphism and body mass index was observed in Korean women with polycystic ovary syndrome but not in control women.
        Fertil Steril. 2014; 102: 1143-1148
        • Kim J.E.
        • Kim J.S.
        • Jo M.J.
        • Cho E.
        • Ahn S.Y.
        • Kwon Y.J.
        • Ko G.J.
        The roles and associated mechanisms of adipokines in development of metabolic syndrome.
        Molecules. 2022; 27: 334
        • King G.A.
        • Deemer S.E.
        • Thompson D.L.
        Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women.
        Acta Diabetol. 2012; 49 Suppl 1: S41-S49
        • Legro R.S.
        • Arslanian S.A.
        • Ehrmann D.A.
        • Hoeger K.M.
        • Murad M.H.
        • Pasquali R.
        • Welt C.K.
        Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.
        J. Clin. Endocrinol. Metab. 2013; 98: 4565-4592
        • Li G.
        • Zhong L.
        • Han L.
        • Wang Y.
        • Li B.
        • Wang D.
        • Zhao Y.
        • Li Y.
        • Zhang Q.
        • Qi L.
        • Speakman J.R.
        • Willi S.M.
        • Li M.
        • Gao S.
        Genetic variations in adiponectin levels and dietary patterns on metabolic health among children with normal weight versus obesity: the BCAMS study.
        Int. J. Obes. (Lond.). 2022; 46: 325-332
        • Li L.
        • Yun J.H.
        • Lee J.H.
        • Song S.
        • Choi B.C.
        • Baek K.H.
        Association study of +45G(T/G) and +276(G/T) polymorphisms in the adiponectin gene in patients with polycystic ovary syndrome.
        Int. J. Mol. Med. 2011; 27: 283-287
        • Lizneva D.
        • Suturina L.
        • Walker W.
        • Brakta S.
        • Gavrilova-Jordan L.
        • Azziz R.
        Criteria, prevalence, and phenotypes of polycystic ovary syndrome.
        Fertil. Steril. 2016; 106: 6-15
        • Mtiraoui N.
        • Ezzidi I.
        • Turki A.
        • Chaieb A.
        • Mahjoub T.
        • Almawi W.Y.
        Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs.
        Diabetes Res. Clin. Pract. 2012; 97: 290-297
        • Nambiar V.
        • Vijesh V.V.
        • Lakshmanan P.
        • Sukumaran S.
        • Suganthi R.
        Association of adiponectin and resistin gene polymorphisms in South Indian women with polycystic ovary syndrome.
        Eur. J. Obstet. Gynecol. Reprod. Biol. 2016; 200: 82-88
        • Nisar S.
        • Shah P.A.
        • Kuchay M.S.
        • Bhat M.A.
        • Rashid A.
        • Ahmed S.
        • Ganie M.A.
        Association of polycystic ovary syndrome and Graves’ disease: is autoimmunity the link between the two diseases.
        Indian J. Endocrinol. Metab. 2012; 16: 982-986
        • Nowak I.
        • Ciećwież S.
        • Łój B.
        • Brodowski J.
        • Brodowska A.
        Adiponectin gene polymorphism (rs17300539) has no influence on the occurrence of metabolic syndrome in women with polycystic ovary syndrome.
        Genes (Basel). 2021; 12: 1902
        • Pau C.
        • Saxena R.
        • Welt C.K.
        Evaluating reported candidate gene associations with polycystic ovary syndrome.
        Fertil. Steril. 2013; 99: 1774-1778
        • Rachoń D.
        Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.
        Exp. Clin. Endocrinol. Diabetes. 2012; 120: 205-209
        • Radavelli-Bagatini S.
        • de Oliveira I.O.
        • Ramos R.B.
        • Santos B.R.
        • Wagner M.S.
        • Lecke S.B.
        • Gigante D.P.
        • Horta B.L.
        • Spritzer P.M.
        Haplotype TGTG from SNP 45T/G and 276G/T of the adiponectin gene contributes to risk of polycystic ovary syndrome.
        J. Endocrinol. Invest. 2013; 36: 497-502
        • Ranjzad F.
        • Mahmoudi T.
        • Irani Shemirani A.
        • Mahban A.
        • Nikzamir A.
        • Vahedi M.
        • Ashrafi M.
        • Gourabi H.
        A common variant in the adiponectin gene and polycystic ovary syndrome risk.
        Mol. Biol. Rep. 2012; 39: 2313-2319
        • Raperport C.
        • Homburg R.
        The source of polycystic ovarian syndrome.
        Clin. Med. Insights Reprod. Health. 2019; 131179558119871467
        • Rasmussen-Torvik L.J.
        • Pankow J.S.
        • Jacobs Jr, D.R.
        • Steinberger J.
        • Moran A.
        • Sinaiko A.R.
        The association of SNPs in ADIPOQ, ADIPOR1, and ADIPOR2 with insulin sensitivity in a cohort of adolescents and their parents.
        Hum. Genet. 2009; 125: 21-28
        • Richardson D.K.
        • Schneider J.
        • Fourcaudot M.J.
        • Rodriguez L.M.
        • Arya R.
        • Dyer T.D.
        • Almasy L.
        • Blangero J.
        • Stern M.P.
        • Defronzo R.A.
        • Duggirala R.
        • Jenkinson C.P.
        Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans.
        Diabetologia. 2006; 49: 2317-2328
        • San Millán J.L.
        • Cortón M.
        • Villuendas G.
        • Sancho J.
        • Peral B.
        • Escobar-Morreale H.F.
        Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.
        J. Clin. Endocrinol. Metab. 2004; 89: 2640-2646
        • Sarray S.
        • Almawi W.Y.
        Levels of CD40L and other inflammatory biomarkers in obese and non-obese women with polycystic ovary syndrome.
        Am. J. Reprod. Immunol. 2016; 76: 285-291
        • Sirmans S.M.
        • Pate K.A.
        Epidemiology, diagnosis, and management of polycystic ovary syndrome.
        Clin. Epidemiol. 2013; 6: 1-13
        • Skiba M.A.
        • Bell R.J.
        • Herbert D.
        • Garcia A.M.
        • Islam R.M.
        • Davis S.R.
        Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
        Hum. Reprod. 2021; 36: 1611-1620
        • Sun X.
        • Wu X.
        • Duan Y.
        • Liu G.
        • Yu X.
        • Zhang W.
        Family-based association study of rs17300539 and rs12495941 polymorphism in adiponectin gene and polycystic ovary syndrome in a Chinese population.
        Med. Sci. Monit. 2017; 23: 78-84
        • Unluhizarci K.
        • Kaltsas G.
        • Kelestimur F.
        Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism.
        Eur. J. Clin. Invest. 2012; 42: 86-94
        • Wang J.
        • Teng F.
        • Wu Q.
        • Wu Y.
        • Hu L.
        Relationship between proinflammatory cytokines and clomiphene resistance in patients with polycystic ovary syndrome.
        Ann. Palliat. Med. 2021; 10: 11884-11890
        • Wassel C.L.
        • Pankow J.S.
        • Jacobs Jr, D.R.
        • Steffes M.W.
        • Li N.
        • Schreiner P.J.
        Variants in the adiponectin gene and serum adiponectin: the Coronary Artery Development in Young Adults (CARDIA) Study.
        Obesity (Silver Spring). 2010; 18: 2333-2338
        • Xita N.
        • Georgiou I.
        • Chatzikyriakidou A.
        • Vounatsou M.
        • Papassotiriou G.P.
        • Papassotiriou I.
        • Tsatsoulis A.
        Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome.
        Clin. Chem. 2005; 51: 416-423
        • Zhang N.
        • Shi Y.H.
        • Hao C.F.
        • Gu H.F.
        • Li Y.
        • Zhao Y.R.
        • Wang L.C.
        • Chen Z.J.
        Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women.
        Eur. J. Endocrinol. 2008; 158: 255-260
        • Zhang W.
        • Wu X.
        • Ding M.
        • Yu X.
        • Liu G.
        • Shi Y.
        Case-control based study between polymorphisms in the adiponectin gene and polycystic ovary syndrome.
        Zhonghua Fu Chan Ke Za Zhi. 2015; 50: 825-829

      Biography

      Wassim Y Almawi is currently Professor of Molecular Medicine, Université de Tunis El Manar, Tunisia. He received his PhD from Dalhousie University, and postdoctorates from the University of Sherbrooke, University of British Columbia and Harvard Medical School. Research areas include polycystic ovary syndrome, diabetes and haemoglobinopathies.
      Key message
      Because the production of adiponectin is genetically determined, and as altered adiponectin concentrations modulate the susceptibility to PCOS, this study reports that specific ADIPOQ gene variants are associated with a heightened risk of PCOS among Bahraini women. This supports ethnic background as a major contributor to ADIPOQ association with PCOS.